Rowinsky Eric K 4
4 · Fortress Biotech, Inc. · Filed Feb 14, 2023
Insider Transaction Report
Form 4
Rowinsky Eric K
DirectorVice Chairman of the Board
Transactions
- Purchase
COMMON STOCK, PAR VALUE $0.001
2023-02-10$0.83/sh+11,976$10,000→ 931,976 total
Footnotes (1)
- [F1]The total holdings include 200,000 shares of deferred restricted stock.